Clinical Trials Logo

Clinical Trial Summary

This is a HEV seroprevalence in the health donors in the Canton Ticino study. The pre-donation sampling pouch of each blood donor coming form the Cantone Ticino region will be collected and tested for HEV serology (IgM and IgG).


Clinical Trial Description

Pre-donation sampling pouch of fresh and stored frozen plasma collected within the last 5 years will be tested for HEV IgG serology at the National Reference Laboratory of the Blood Transfusion Services SRC in Berne Collected data will be used to determine HEV seroprevalence, actual and in the last 5 years, in the Canton Ticino and to investigate trend and pattern of the HEV infection (seroprevalence by different regional areas, comparison with national HEV data, and correlation with age, sex and place of residence). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03601221
Study type Observational
Source Ente Ospedaliero Cantonale, Bellinzona
Contact
Status Completed
Phase
Start date May 29, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03365921 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) Phase 4
Completed NCT02584543 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) Phase 4
Not yet recruiting NCT03488589 - HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
Completed NCT03168412 - A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) Phase 4
Completed NCT02189603 - Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®) Phase 4
Completed NCT02847507 - Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
Completed NCT02603055 - A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults Phase 1
Completed NCT02190253 - Seroprevalence of Hepatitis E in People With an Organ Transplant
Completed NCT04670419 - Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Completed NCT03282474 - HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) Phase 2
Terminated NCT02558114 - Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. Phase 4
Recruiting NCT06137313 - Exposure to Hepatitis E Virus in Occitania, France
Completed NCT02964910 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) Phase 4
Completed NCT01014845 - Clinical Trial of Recombinant Hepatitis E Vaccine Phase 3
Recruiting NCT05976594 - Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
Completed NCT02417597 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) Phase 4
Completed NCT03827395 - Safety Study of Hepatitis E Vaccine (HEV239) Phase 1